5 terminated. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Ischemic Heart Disease: new trials by email Literature Review of Ischemic Heart Disease trials Research Report on Ischemic Heart Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ozone Therapy in Refractory Ischemic Heart Disease. Ozone, Oxygen - Ischemic Heart Disease | Phase 2 / Phase 3 | Terminated | Bernardino Clavo, MD, PhD | 1 | 2020-02-26 | 2022-04-04 |
| Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC), Placebo - Ischemic Heart Disease, Non-ischemic Cardiomyopathy | Phase 2 | Terminated | Medstar Health Research Institute | 4 | 2019-05-03 | 2022-02-02 |
| Autologous Cell Therapy for Ischemic Heart Failure AMDC - Ischemic Heart Disease | Phase 1 / Phase 2 | Terminated | Cook MyoSite | 9 | 2011-02-05 | 2021-07-01 |
| A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging apadenoson - Cardiovascular Disease, Ischemic Heart Disease | Phase 2 | Terminated | Forest Laboratories | 20 | 2005-07-01 | 2017-02-01 |
| Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack. Cellular Therapy (Cultured Autologous Skeletal Myoblast Transplantation) - Ischemic Heart Failure, Ischemic Heart Disease | Phase 2 | Terminated | Genzyme, a Sanofi Company | 2002-11-01 | 2015-05-22 |
Myocardial Ischemia (5) · Heart Failure (2) · Cardiovascular Diseases (1) · Heart Diseases (1) · Myocardial Infarction (1)
Vascular Diseases (5) · Cardiovascular Diseases (4) · Heart Diseases (4) · Infarction (1) · Ischemia (1) · Necrosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Cell- and Tissue-Based Therapy (1) · Oxygen (1) · Ozone (1)
Bernardino Clavo, MD, PhD (1) · Cook MyoSite (1) · Forest Laboratories (1) · Genzyme, a Sanofi Company (1) · Medstar Health Research Institute (1)
United States (2) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Bernardino Clavo, MD, PhD (1) · Celestina Amador, MD, PhD (1) · E Gordon DePuey, MD (1) · Hung Q. Ly, MD (1) · Pedro G Serrano-Aguilar, MD, PhD (1)
2018 (1)